|1.||de Korte, Dirk: 2 articles (07/2015 - 06/2008)|
|2.||Acker, Jason P: 2 articles (05/2015 - 10/2014)|
|3.||Kaminsky, Yury G: 2 articles (02/2014 - 01/2013)|
|4.||Aliev, Gjumrakch: 2 articles (02/2014 - 01/2013)|
|5.||Reddy, V Prakash: 2 articles (02/2014 - 01/2013)|
|6.||Kosenko, Elena A: 2 articles (02/2014 - 01/2013)|
|7.||Carreras, José: 2 articles (03/2011 - 01/2004)|
|8.||Climent, Fernando: 2 articles (03/2011 - 01/2004)|
|9.||Detry, Bruno: 2 articles (12/2008 - 11/2002)|
|10.||Aydoğan, S: 1 article (08/2015)|
10/01/1995 - "2,3-Diphosphoglycerate was induced only during the recovery phase of the study and corresponded to a gradual response to hypoxia. "
02/01/2011 - "The considerable rise of 2,3-diphosphoglycerate suggests tissue hypoxia. "
04/06/2007 - "The allostery-dependent interaction of Hb with BIII appeared to contribute not only to maintenance of energy charge but also to further synthesis of 2,3-bisphosphoglycerate, which could help sustain stabilization of T-state Hb during hypoxia. "
10/01/2004 - "Higher 2,3-DPG levels could partly explain this decreased sensitivity of the EPO response to hypoxia. "
04/01/2000 - "Red cell 2,3-DPG rose from baseline a value of 5.0+/-0.8 to 5.9+/-0.7 mmol x L(-1) (P < 0.05) after the first day in continuous hypoxia and from 5.2+/-0.7 mmol x L(-1) to 6.1+/-0.5 mmol x L(-1) on day 3 (P < 0.05) during intermittent hypoxia. "
07/01/1978 - "Physiologic features of hemolysis axxociated with altered cation and 2,3-diphosphoglycerate content."
06/01/1977 - "Pediatrics, 59:1027-1031, 1977 PHOTOTHERAPY, 2,3-DIPHOSPHOGLYCERATE, HEMOLYSIS, NEWBORN INFANT."
04/15/1986 - "We have concluded that during intravascular hemolysis 2,3-DPG release may be a key component in preventing and/or inducing thrombosis."
12/01/1983 - "The absence of anemia despite hemolysis may be explained by the low 2,3-DPG levels. "
04/01/1980 - "The paradox of mild erythrocytosis despite hemolysis reflects the decreased production of 2,3-DPG."
|3.||Chronic Obstructive Pulmonary Disease (COPD)
01/01/1990 - "48 simultaneous arterial and venous blood samples from 15 patients with chronic obstructive pulmonary disease (COPD) were evaluated for calculated p50 and measured and calculated 2,3-diphosphoglycerate (DPG) concentration. "
01/01/1977 - "2,3-DPG and P50 were measured in 23 patients with chronic obstructive lung disease. "
01/01/1971 - "[Erythrocyte 2,3-diphosphoglycerate content in chronic obstructive lung disease]."
12/01/1987 - "The erythrocyte 2,3-diphosphoglycerate (2,3-DPG) was studied in patients with liver diseases, chronic obstructive pulmonary disease, and in normal subjects. "
01/01/1988 - "In vivo study, after administration of pentoxifylline 300 mg per day orally for 4 weeks to seven patients with COPD, P50 increased significantly from 29.0 +/- 0.6 to 30.4 +/- 0.6 Torr (p less than 0.05) and 2,3-DPG increased slightly from 11.67 +/- 0.56 to 14.33 +/- 1.12 mumol/gHb (p less than 0.1). "
09/01/1997 - "The right-shifted p50 from whole blood can be easily explained by the mild anemia with a parallel increase of 2,3-diphosphoglycerate (DPG), whereas the functional discrepancies between whole blood function and that of the purified Hb-S and C could be due, at least in part, to the presence in vivo of consistent amounts of hybrid Hb tetramers of the type alpha alpha beta S beta C. "
09/01/1992 - "Erythrocyte concentrations of 2,3-diphosphoglycerate (DPG) were significantly increased in anemic animals and showed a close correlation to the degree of anemia. "
02/01/1992 - "The level of 2,3-diphosphoglycerate of the red cells increased with the degree of anemia."
07/01/1991 - "In less severe anemia there was more active utilization in glycolysis of 2,3-DPG and ATR in the presence of manifest oxidation of intraerythrocytic medium typical for Root effect predominance. "
01/01/1991 - "The slight increase observed in the P50 of whole blood is not intrinsic to the beta 139 substitution, but is thought to result from an increased 2,3-diphosphoglycerate level in response to anemia. "
12/01/1988 - "These metabolic changes include a deprivation of 2,3-diphosphoglycerate (2,3-DPG), acidosis and hyperkalemia. "
01/01/1977 - "hypophosphatemia and acidosis which lower the concentration of red cell 2,3-diphosphoglycerate. "
11/01/1972 - "Red cell 2,3-diphosphoglycerate and intracellular arterial pH in acidosis and alkalosis."
01/01/1992 - "There was a drop in 2,3-DPG level intraoperatively, which was due to the use of stored donor blood for blood loss compensation and to mounting metabolic acidosis (lactate acidosis included) and gaseous acidosis."
01/01/1986 - "During severe lactacidosis and HCL-induced acidosis a decrease in 2,3-DPG due to an inhibition of 2,3-DPGmutase and other glycolytic enzymes can be found. "
|6.||Adenosine Triphosphate (ATP)
|1.||Renal Dialysis (Hemodialysis)
|3.||Total Parenteral Nutrition
|4.||Dilatation and Curettage (D&C)
|5.||Blood Transfusion (Blood Transfusions)